NCT00379249View on ClinicalTrials.gov

Rosuvastatin ORBITAL Germany

PHASE3CompletedINTERVENTIONAL

Enrollment

8,000

Participants

Timeline

Start Date

February 28, 2002

Study Completion Date

February 29, 2004

Conditions

Hypercholesterolemia

Interventions

DRUG

Rosuvastatin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY